BNTX
Price:
$90.89
Market Cap:
$20.09B
BioNTech SE, a biotechnology firm, specializes in the creation and marketing of immune-based treatments for malignancies and various infectious diseases. A significant part of its oncology pipeline includes the FixVac cancer vaccine program, which features several candidates in different phases of clinical development: BNT111 is in Phase 2 for advanced melanoma. BNT112 has reached Phase 1/2a for prostate cancer. BNT113 is undergoing Phase 2 investigation for HPV-positive head and neck cancers. BNT114 is in Phase 1 for triple-negative breast cancer. BNT115 is also in Phase 1, targeting ovarian cancer. BNT116 is a preclinical candidate for non-small cell lung cancer. The company also pioneers ...[Read more]
Industry
Biotechnology
IPO Date
2019-10-10
Stock Exchange
NASDAQ
Ticker
BNTX
According to BioNTech SE’s latest financial reports and current stock price. The company's current Enterprise Value is 10.46B. This represents a change of -5.41% compared to the average of 11.05B of the last 4 quarters.
The mean historical Enterprise Value of BioNTech SE over the last ten years is 13.96B. The current 10.46B Enterprise Value has changed 7.39% with respect to the historical average. Over the past ten years (40 quarters), BNTX's Enterprise Value was at its highest in in the September 2021 quarter at 56.52B. The Enterprise Value was at its lowest in in the June 2018 quarter at 0.
Average
13.96B
Median
11.84B
Minimum
-277011000.00
Maximum
50.90B
Discovering the peaks and valleys of BioNTech SE Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 213.94%
Maximum Annual Enterprise Value = 50.90B
Minimum Annual Increase = -1118.23%
Minimum Annual Enterprise Value = -277011000.00
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 12.25B | -26.28% |
| 2024 | 16.62B | 45.60% |
| 2023 | 11.42B | -45.96% |
| 2022 | 21.13B | -58.49% |
| 2021 | 50.90B | 213.94% |
| 2020 | 16.21B | 170.95% |
| 2019 | 5.98B | 131.46% |
| 2018 | 2.59B | -8.35% |
| 2017 | 2.82B | -1118.23% |
The current Enterprise Value of BioNTech SE (BNTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
13.43B
5-year avg
22.46B
10-year avg
13.96B
BioNTech SE’s Enterprise Value is less than Incyte Corporation (16.20B), less than Genmab A/S (19.25B), less than United Therapeutics Corporation (21.70B), less than Teva Pharmaceutical Industries Limited (50.41B), less than DexCom, Inc. (28.23B), less than Natera, Inc. (32.29B), less than Koninklijke Philips N.V. (28.35B), less than STERIS plc (21.39B), less than Royalty Pharma plc (31.15B), less than Biogen Inc. (32.20B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 16.20B | $19.62B | |
| 19.25B | $15.51B | |
| 21.70B | $22.78B | |
| 50.41B | $36.66B | |
| 28.23B | $27.96B | |
| 32.29B | $33.14B | |
| 28.35B | $26.01B | |
| 21.39B | $19.75B | |
| 31.15B | $22.78B | |
| 32.20B | $29.02B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioNTech SE using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BioNTech SE or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is BioNTech SE's Enterprise Value?
What is the highest Enterprise Value for BioNTech SE (BNTX)?
What is the 3-year average Enterprise Value for BioNTech SE (BNTX)?
What is the 5-year average Enterprise Value for BioNTech SE (BNTX)?
How does the current Enterprise Value for BioNTech SE (BNTX) compare to its historical average?